Inventor · disambiguated record
Junran Yang
Also filed as: YANG JUNRAN
1 granted patent·8 pending applications·0 citations·filing 2019–2023
4Inventor score
Top patents by PatentIndex Score
9 records- 0160US2025382287A1Pharmaceutically acceptable salt and crystal form of nitrogen-containing bridge heterocyclic derivative, and method for preparing sameJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0254US2025145641A1Fused bicyclic derivative, pharmaceutically acceptable salt, crystal form thereof and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0354US2025154126A1Crystalline form of sulfur-containing isoindoline derivativeJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0454US2025049777A1Pharmaceutically acceptable salt and crystalline form of glp-1 receptor agonist and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0550US2025049778A1Crystalline form of glp-1 receptor agonist and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0650US2024374581A1Salt types of tricyclic tetrahydro isoquinoline derivativeJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0746US2024262823A1Pharmaceutically acceptable salt of pyrazoloheteroaryl derivative and crystal form thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0845US11299462B2Crystal form of oxopicolinamide derivative and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Apr 12, 2022·0 cites·19 claims
- 0941US2021355109A1Crystal form of maleate of tyrosine kinase inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Junran Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →